Drug Pipeline

Dalfampridine 10 MG [Ampyra] Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
6
Active Studies
4
Recruiting
5
Top Sponsors
Active Studies by Phase
Phase 4
1
Phase 2
2
Phase 1/2
1
Phase 1
1
Not specified
1
Active Trials
NCT IDTitleConditionStatus
Phase 4
NCT06136728 Dalfampridine Combined With Physical Therapy for Mobility Impairment in Multiple Sclerosis Multiple Sclerosis Recruiting
Phase 2
NCT06596434 4-Aminopyridine to Treat Skin Burns Burns Recruiting
NCT06294821 4AP for Carpal Tunnel Syndrome (CTS) Compression Neuropathy Not Yet Recruiting
Phase 1/2
NCT06853015 Double Dose 4-AP on Functional Recovery After Spinal Cord Injury SCI - Spinal Cord Injury Recruiting
Phase 1
NCT07171203 Preoperative Imatinib and Fampridine in KIT Mutant Gastrointestinal Stromal Tumor Gastrointestinal Stromal Tumors Recruiting
Not specified
NCT07532460 The Role of Potassium Channels in Working Memory Impairments of Chronic Cocaine Users Cocaine Use Disorder (CUD) Not Yet Recruiting
Sponsors Running Dalfampridine 10 MG [Ampyra] Trials
Disease Areas
Get alerts when Dalfampridine 10 MG [Ampyra] trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free